These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

687 related items for PubMed ID: 30922247

  • 1. Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer.
    Sandberg TP, Stuart MPME, Oosting J, Tollenaar RAEM, Sier CFM, Mesker WE.
    BMC Cancer; 2019 Mar 29; 19(1):284. PubMed ID: 30922247
    [Abstract] [Full Text] [Related]

  • 2. Comparisons of cancer-associated fibroblasts in the intratumoral stroma and invasive front in colorectal cancer.
    Son GM, Kwon MS, Shin DH, Shin N, Ryu D, Kang CD.
    Medicine (Baltimore); 2019 May 29; 98(18):e15164. PubMed ID: 31045759
    [Abstract] [Full Text] [Related]

  • 3. High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosis.
    Wikberg ML, Edin S, Lundberg IV, Van Guelpen B, Dahlin AM, Rutegård J, Stenling R, Oberg A, Palmqvist R.
    Tumour Biol; 2013 Apr 29; 34(2):1013-20. PubMed ID: 23328994
    [Abstract] [Full Text] [Related]

  • 4. The prognostic significance of cancer-associated fibroblasts in esophageal squamous cell carcinoma.
    Ha SY, Yeo SY, Xuan YH, Kim SH.
    PLoS One; 2014 Apr 29; 9(6):e99955. PubMed ID: 24945657
    [Abstract] [Full Text] [Related]

  • 5. Altered expression of fibroblast activation protein-α (FAP) in colorectal adenoma-carcinoma sequence and in lymph node and liver metastases.
    Solano-Iturri JD, Beitia M, Errarte P, Calvete-Candenas J, Etxezarraga MC, Loizate A, Echevarria E, Badiola I, Larrinaga G.
    Aging (Albany NY); 2020 May 19; 12(11):10337-10358. PubMed ID: 32428869
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Investigating the complex interplay between fibroblast activation protein α-positive cancer associated fibroblasts and the tumor microenvironment in the context of cancer immunotherapy.
    Kraxner A, Braun F, Cheng WY, Yang TO, Pipaliya S, Canamero M, Andersson E, Harring SV, Dziadek S, Bröske AE, Ceppi M, Tanos T, Teichgräber V, Charo J.
    Front Immunol; 2024 May 19; 15():1352632. PubMed ID: 39035007
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma.
    Higashino N, Koma YI, Hosono M, Takase N, Okamoto M, Kodaira H, Nishio M, Shigeoka M, Kakeji Y, Yokozaki H.
    Lab Invest; 2019 Jun 19; 99(6):777-792. PubMed ID: 30683902
    [Abstract] [Full Text] [Related]

  • 13. Cancer-associated fibroblasts expressing fibroblast activation protein and podoplanin in non-small cell lung cancer predict poor clinical outcome.
    Mathieson L, Koppensteiner L, Dorward DA, O'Connor RA, Akram AR.
    Br J Cancer; 2024 May 19; 130(11):1758-1769. PubMed ID: 38582812
    [Abstract] [Full Text] [Related]

  • 14. [Multiplex fluorescent imaging of cancer-associated fibroblasts in colorectal cancer].
    Oleynikova NA, Kharlova OA, Danilova NV, Malkov PG.
    Arkh Patol; 2022 May 19; 84(5):11-19. PubMed ID: 36178217
    [Abstract] [Full Text] [Related]

  • 15. Fibroblast activation protein-α-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma.
    Kawase T, Yasui Y, Nishina S, Hara Y, Yanatori I, Tomiyama Y, Nakashima Y, Yoshida K, Kishi F, Nakamura M, Hino K.
    BMC Gastroenterol; 2015 Sep 02; 15():109. PubMed ID: 26330349
    [Abstract] [Full Text] [Related]

  • 16. Blockade of fibroblast activation protein in combination with radiation treatment in murine models of pancreatic adenocarcinoma.
    Gunderson AJ, Yamazaki T, McCarty K, Phillips M, Alice A, Bambina S, Zebertavage L, Friedman D, Cottam B, Newell P, Gough MJ, Crittenden MR, Van der Veken P, Young KH.
    PLoS One; 2019 Sep 02; 14(2):e0211117. PubMed ID: 30726287
    [Abstract] [Full Text] [Related]

  • 17. FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling.
    Yang X, Lin Y, Shi Y, Li B, Liu W, Yin W, Dang Y, Chu Y, Fan J, He R.
    Cancer Res; 2016 Jul 15; 76(14):4124-35. PubMed ID: 27216177
    [Abstract] [Full Text] [Related]

  • 18. Broadening Drug Design and Targets to Tumor Microenvironment? Cancer-Associated Fibroblast Marker Expression in Cancers and Relevance for Survival Outcomes.
    Dzobo K, Dandara C.
    OMICS; 2020 Jun 15; 24(6):340-351. PubMed ID: 32496971
    [Abstract] [Full Text] [Related]

  • 19. FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells.
    Lee HO, Mullins SR, Franco-Barraza J, Valianou M, Cukierman E, Cheng JD.
    BMC Cancer; 2011 Jun 13; 11():245. PubMed ID: 21668992
    [Abstract] [Full Text] [Related]

  • 20. Endoglin Expression on Cancer-Associated Fibroblasts Regulates Invasion and Stimulates Colorectal Cancer Metastasis.
    Paauwe M, Schoonderwoerd MJA, Helderman RFCP, Harryvan TJ, Groenewoud A, van Pelt GW, Bor R, Hemmer DM, Versteeg HH, Snaar-Jagalska BE, Theuer CP, Hardwick JCH, Sier CFM, Ten Dijke P, Hawinkels LJAC.
    Clin Cancer Res; 2018 Dec 15; 24(24):6331-6344. PubMed ID: 29945992
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.